Fiscal Year January-December.

All Values are in USD Millions 2016 2017

Sales/Revenue 52,824 1.00 52,546
-0.53%
Cost of sales 12,329 23.34% 11,240
Selling, informational and administrative expenses 14,837 28.09% 14,784
-0.36%
Research and development expenses 7,872 14.90% 7,657
-2.73%
Amortization of intangible assets 4,056 7.68% 4,758
17.31%
Restructuring charges and certain acquisition-related costs 1,724 3.26% 487
-71.75%
Other (income)/deductions—net 3,655 6.92% 1,315
Income from continuing operations before provision/ (benefit) for 8,351 15.81% 12,305
taxes on income
Provision/(benefit) for taxes on income 1,123 2.13% -9,049
Income from continuing operations 7,228 13.68% 21,354
Discontinued operations—net of tax 17 0.03% 2
Net income before allocation to noncontrolling interests 7,245 13.72% 21,356
Less: Net income attributable to noncontrolling interests 31 0.06% 47
Net income attributable to Pfizer Inc 7,214 13.66% 21,309
EPS (Basic} 1.18 0.00% 3.57
EPS (Basic) Growth 4.63% 0.00% 202.40%
Basic Shares Outstanding 6,089 11.53% 5,970
EPS (Diluted} 1.17 0.00% 3.52
EPS (Diluted) Growth 5.09% 0.00% 200.60%
Diluted Shares Outstanding 6,159 11.66% 6,058
EBITDA 20,031 37.92% 20,660
EBITDA Growth 8.55% 0.00% 3.14%
EBITDA Margin - -
 2018
1.01 53,647 1.00
2.10%
21.39% 11,248 20.97%
28.14% 14,455 26.94%
-2.23%
14.57% 8,006 14.92%
4.56%
9.05% 4,893 9.12%
2.84%
0.93% 1,044 1.95%
114.37%
2.50% 2,116 3.94%

23.42% 11,885 22.15%

-17.22% 706 1.32%

40.64% 11,179 20.84%
0.00% 10 0.02%
40.64% 11,189 20.86%
0.09% 36 0.07%
40.55% 11,153 20.79%
0.01% 1.9 0.00%
0.00% -46.78% 0.00%
11.36% 5,872 10.95%
0.01% 1.87 0.00%
0.00% -46.94% 0.00%
11.53% 5,977 11.14%
39.32% 21,673 40.40%
0.00% 4.90% 0.00%
40.40%
 Fiscal Year January-December. All Values are in USD Millions 2016 2017 2018
Cash Only 2,595 1,342 1,139
Short-Term Investments 15,255 18,650 17,694
Total Accounts Receivable 8,225 8,221 8,025
Accounts Receivable, Gross 8,834 8,805 8,566
Bad Debt/Doubtful Accounts -609 -584 -541
Inventories 6,783 7,578 7,508
Other Current Assets 6,091 5,350 15,560
Total Current Assets 38,949 41,141 49,926
Net Property, Plant & Equipment 13,318 13,865 13,385
Long-term investments 7,116 7,015 2,767
Intangible Assets 52,648 48,741 13,385
Net Goodwill 54,449 55,952 35,211
Net Other Intangibles 1,812 1,855 53,411
Tangible Other Assets 3,323 3,228 1,924
Total no current assets 132,666 130,656 120,083
Total Assets 171,615 171,797 170,009

Liabilities & Shareholders' Equity

ST Debt & Current Portion LT Debt 10,688 9,953 8,831
Accounts Payable 4,536 4,656 4,674
Dividends payable 1,944 2,029 2,047
Income Tax Payable 437 477 1,265
Accrued compensation and related items 2,487 2,196 2,397
Other current liabilities 11,023 11,116 12,643
Total Current Liabilities 31,115 30,427 31,858
Long-Term Debt 31,398 33,538 32,909
Pension benefit obligations, net 6,406 5,926 5,272
Postretirement benefit obligations, net 1,766 1,504 1,338
Noncurrent deferred tax liabilities 30,753 3,900 3,700
Other taxes payable 4000 18697 14736
Other noncurrent liabilities 6337 6149 5850
Total no Current Liabilities 80,660 69,714 63,805
Total Liabilities 111,775 100,141 95,663
Total Liabilities / Total Assets 65.13% 58.29% 56.27%
Equity
Preferred stock, no par value, 24 21 19
Common stock, 461 464 467
Additional paid-in capital 82685 84278 86253
Treasury stock -84,364 -89,425 -101,610
Retained earnings 71,774 85,291 89,554
Accumulated other comprehensive loss -11036 -9321 -11275
Equity attributable to noncontrolling interests 296 348 351
Total Equity 59840 71656 63759
Total Liabilities & Shareholders' Equity 171,615 171,797 159,422
Rotaion Inventario Crecimiento
198 243 240
Rotacion cunetas por pagar

Pasivos Activos
28% 30% 33% 23% 24% 29% AC
72% 70% 67% 77% 76% 71% ANC
100% 100% 100% 0% 100% 100% 100%

132 149 150